AXT PTY LTD is a leading distributor of advanced technologies for life sciences and biomedical research in Australia and New Zealand. Their portfolio includes cutting-edge 3D bioprinters, organ-on-chip platforms, cell culture innovations and powerful imaging tools that empower researchers to push the frontiers of regenerative medicine, drug discovery and tissue engineering. They also have a comprehensive preclinincal imaging portfolio to facilitate the transition to clinical testing. With strong global partnerships and local expertise and servicing, AXT is committed to supporting scientists with transformative tools that accelerate breakthroughs in healthcare and life sciences.
MAWA’s aim is to advance medical science and improve human health without using animals or animal products in medical research. MAWA has taken a leading role in animal-free science by providing funding to universities and research institutions throughout Australia and working cooperatively and productively with the scientific research community to facilitate the development and promotion of human-relevant non-animal methods.
MAWA provides research grants, travel grants, equipment grants, fellowships, scholarships, conference bursaries, support for tissue banks, and sponsorships for training courses, significant seminars and conferences. MAWA works in partnership with the Australian National University (ANU) where it has established the Replacing Animals in Medical Research Fund (RAMR). MAWA also facilitates third-party funding for all these initiatives to increase opportunities for researchers and students to replace the use of animals in medical research.
ATA Scientific supports a range of specialised analytical instruments focused in the areas of Particle, Material, Biomolecular Science and SEM/Imaging. Visit our trade table and discover:
Micropore AXF Pathfinder, enables continuous, reproducible, and scalable manufacture of nanoparticles such as LNPs to encapsulate RNA through one single stainless steel membrane mixing element — from formulation (0.2-200mL) to full GMP (500ml/min).
EXODUS H-600 automatic exosome isolation system enables high-quality intact exosomes to be quickly and easily isolated with excellent yield and purity from various biofluids (including blood, tears, urine, and saliva) and various sample volumes. Achieve purity levels of ~98% and yields beyond 90%, all while reducing hands-on time from hours to just minutes.
Malvern NanoSight Pro, faster, easier and more accurate Nanoparticle Tracking Analysis to allow the highest quality size and concentration data for both the light scatter and fluorescence analysis.
Malvern Zetasizer Ultra builds on the legacy of the industry-leading Zetasizer Nano adding high-resolution sizing (Multi-Angle Dynamic Light Scattering) and particle concentration capabilities.
Revivo Biosystems is a Singapore-based lab automation and tissue engineering startup, specialized in 4D organ-on-a-chip platform and lab-grown reconstructed barrier tissue models. Revivo Biosystems aims to accelerate preclinical studies for cosmetics, pharmaceuticals and food industries, allowing them to gain deeper biological insights.
Craft Health is a Singapore-based healthcare and technology company providing automated platform solutions for personalised medicine and supplements. We provide a cutting-edge, innovative, and user-friendly platform that automates the production of personalized medicines, transforming healthcare and improving patient outcomes globally.
Established in 2019 by a team of pharmacists, our platform integrates patented hardware (no heat and UV), software, and standard premix materials. These solutions have been widely adopted across pharmacies, universities, and hospitals for research and development, just-in-time production of high-mix low-volume products, and educational programs.
RR MedSciences is a Sydney-based, clinical stage pharmaceutical company progressing therapeutic candidates for the treatment of pain and inflammatory conditions.
Taron Solutions is a rising global partnering and drug development accelerator specializing in biologic therapeutics. Over the years, we have successfully helped different products by leveraging our proprietary technology platforms as well as our team's combined 150+ years of international biotech experience in research, formulation, and process development to expedite regulatory approval pathway.
